{"Q": 1, "answer": "no", "rationale": "'very quickly' contains an adverb modifying an adverb, not an intensifier/comparative modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_19512", "batch_size": 200, "batch_pos": 168, "statement_text": "The company plans to launch a small human trial of an mRNA pandemic flu vaccine tailored to the new avian influenza subtype in the first half of 2023, he [Raffael Nachbagauer] said, adding Moderna could respond very quickly in an outbreak scenario.", "article_id": 1272}
{"Q": 2, "answer": "no", "rationale": "The segment states factual information about plans and capability without high-potency language.", "method": "llm_batch", "batch_id": "batch_2_16796", "batch_size": 200, "batch_pos": 134, "statement_text": "The company plans to launch a small human trial of an mRNA pandemic flu vaccine tailored to the new avian influenza subtype in the first half of 2023, he [Raffael Nachbagauer] said, adding Moderna could respond very quickly in an outbreak scenario.", "article_id": 1272}
{"Q": 3, "answer": "no", "rationale": "No moderate verb paired with explicit scale or impact information.", "method": "llm_batch", "batch_id": "batch_3_17156", "batch_size": 200, "batch_pos": 37, "statement_text": "The company plans to launch a small human trial of an mRNA pandemic flu vaccine tailored to the new avian influenza subtype in the first half of 2023, he [Raffael Nachbagauer] said, adding Moderna could respond very quickly in an outbreak scenario.", "article_id": 1272}
{"Q": 4, "answer": "no", "rationale": "The segment does not contain a loaded rhetorical question.", "method": "llm_batch", "batch_id": "batch_4_18292", "batch_size": 200, "batch_pos": 29, "statement_text": "The company plans to launch a small human trial of an mRNA pandemic flu vaccine tailored to the new avian influenza subtype in the first half of 2023, he [Raffael Nachbagauer] said, adding Moderna could respond very quickly in an outbreak scenario.", "article_id": 1272}
{"Q": 5, "answer": "no", "rationale": "Reports plans and capability, not a calming cue about current safety.", "method": "llm_batch", "batch_id": "batch_5_16308", "batch_size": 200, "batch_pos": 25, "statement_text": "The company plans to launch a small human trial of an mRNA pandemic flu vaccine tailored to the new avian influenza subtype in the first half of 2023, he [Raffael Nachbagauer] said, adding Moderna could respond very quickly in an outbreak scenario.", "article_id": 1272}
{"Q": 6, "answer": "no", "rationale": "The segment contains 'small human trial', where 'small' is not a listed minimiser.", "method": "llm_batch", "batch_id": "batch_6_14016", "batch_size": 200, "batch_pos": 184, "statement_text": "The company plans to launch a small human trial of an mRNA pandemic flu vaccine tailored to the new avian influenza subtype in the first half of 2023, he [Raffael Nachbagauer] said, adding Moderna could respond very quickly in an outbreak scenario.", "article_id": 1272}
{"Q": 7, "answer": "no", "rationale": "The segment contains a Q5 calming cue ('could respond very quickly').", "method": "llm_batch", "batch_id": "batch_7_19992", "batch_size": 200, "batch_pos": 174, "statement_text": "The company plans to launch a small human trial of an mRNA pandemic flu vaccine tailored to the new avian influenza subtype in the first half of 2023, he [Raffael Nachbagauer] said, adding Moderna could respond very quickly in an outbreak scenario.", "article_id": 1272}
{"Q": 8, "answer": "yes", "rationale": "States company 'plans to launch a small human trial' and 'could respond very quickly' which are capability/preparedness statements, without calming keywords.", "method": "llm_batch", "batch_id": "batch_8_16996", "batch_size": 200, "batch_pos": 190, "statement_text": "The company plans to launch a small human trial of an mRNA pandemic flu vaccine tailored to the new avian influenza subtype in the first half of 2023, he [Raffael Nachbagauer] said, adding Moderna could respond very quickly in an outbreak scenario.", "article_id": 1272}
